← Screener

ELVElevance Health

Health care · Health Insurance · NYSE

Compare with peers → Embed

Filings with the SEC since Oct 3, 2013

1,009 filings, 8 in the last 30 days

SEC filing index

Latest annual reportOpen ↗

Feb 6, 2026

10-K, period to Dec 31, 2025

Latest quarterly reportOpen ↗

Oct 21, 2026

10-Q, period to Sep 30, 2026

Latest current reportOpen ↗

Nov 10, 2026

8-K: Regulation FD disclosure

Filed in the last 30 days

of 1,009 in all

Timeline

Every filing on one line

1 yr 2 yr 3 yr

Annual report (10-K)Quarterly report (10-Q)Current report (8-K)Auditor changeCEO, CFO, COO or CAO changeRestatementLate filing noticeInsider purchaseCluster buy (3+ insiders)SEC comment letterShare offering (S-3, 424B)

20252026

All 35 events

Nov 10, 20268-K Regulation FD disclosure 8-K item 7.01
Oct 28, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · We may offer and sell, from time to time, one or any combination of the securities we describe in this prospectus.
Oct 21, 20268-K Quarterly results 8-K item 2.02
Oct 21, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026
Sep 10, 20268-K Regulation FD disclosure 8-K item 7.01
Jul 17, 2026Buy PERU RAMIRO G (Director) bought $366K open-market purchase on Jul 17, 2026
Jul 17, 2026Buy BOUDREAUX GAIL (President and CEO) bought $1.0M open-market purchase on Jul 17, 2026
Jul 15, 20268-K Quarterly results 8-K item 2.02
Jul 15, 202610-Q Quarterly report (10-Q) period ended Jun 30, 2026
Jun 10, 20268-K Regulation FD disclosure 8-K item 7.01
May 13, 20268-K Shareholder vote results 8-K item 5.07
Apr 22, 20268-K Quarterly results 8-K item 2.02
Apr 22, 202610-Q Quarterly report (10-Q) period ended Mar 31, 2026
Mar 10, 20268-K Regulation FD disclosure 8-K item 7.01
Mar 2, 20268-K Other events 8-K item 8.01
Feb 26, 20268-K Director or officer change, Regulation FD disclosure 8-K items 5.02, 7.01
Feb 6, 202610-K Annual report (10-K) period ended Dec 31, 2025
Jan 28, 20268-K Quarterly results 8-K item 2.02
Dec 10, 20258-K Director or officer change 8-K item 5.02
Nov 10, 20258-K Regulation FD disclosure 8-K item 7.01
Oct 21, 20258-K Quarterly results 8-K item 2.02
Oct 21, 202510-Q Quarterly report (10-Q) period ended Sep 30, 2025
Sep 15, 20258-K Other events 8-K item 8.01
Sep 4, 20258-K Regulation FD disclosure 8-K item 7.01
Jul 28, 20258-K Director or officer change 8-K item 5.02
Jul 17, 20258-K Quarterly results 8-K item 2.02
Jul 17, 202510-Q Quarterly report (10-Q) period ended Jun 30, 2025
May 28, 20258-K Regulation FD disclosure 8-K item 7.01
May 14, 20258-K Shareholder vote results 8-K item 5.07
Apr 22, 20258-K Quarterly results 8-K item 2.02
Apr 22, 202510-Q Quarterly report (10-Q) period ended Mar 31, 2025
Apr 17, 20258-K Quarterly results, Regulation FD disclosure 8-K items 2.02, 7.01
Mar 10, 20258-K Regulation FD disclosure 8-K item 7.01
Feb 20, 202510-K Annual report (10-K) period ended Dec 31, 2024
Jan 23, 20258-K Quarterly results 8-K item 2.02

From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).

Every filing

Newest first, by kind

Each form links to sec.gov

All 1009 Annual & quarterly 54 Current reports (8-K) 169 Insiders 561 Proxy & votes 39 Big owners (13D/13G) 44 Shares & debt offered 47 SEC letters 6 Other 89

Filed	Form	What it is	Period
Apr 7, 2026	PX14A6G	Shareholder's proxy letter		all files
Mar 27, 2026	DEFA14A	Extra proxy material		all files
Mar 27, 2026	DEF 14A	Proxy statement	May 13, 2026	all files
Apr 14, 2025	PX14A6G	Shareholder's proxy letter		all files
Mar 28, 2025	DEFA14A	Extra proxy material		all files
Mar 28, 2025	DEFA14A	Extra proxy material		all files
Mar 28, 2025	DEF 14A	Proxy statement	May 14, 2025	all files
Apr 22, 2024	DEFA14A	Extra proxy material		all files
Mar 29, 2024	DEFA14A	Extra proxy material		all files
Mar 29, 2024	DEF 14A	Proxy statement	May 15, 2024	all files
Mar 31, 2023	DEFA14A	Extra proxy material		all files
Mar 31, 2023	DEF 14A	Proxy statement		all files
May 6, 2022	DEFA14A	Extra proxy material		all files
Apr 1, 2022	DEFA14A	Extra proxy material		all files
Apr 1, 2022	DEF 14A	Proxy statement	May 18, 2022	all files
Mar 11, 2022	PRE 14A		Dec 31, 2021	all files
Apr 9, 2021	DEFA14A	Extra proxy material		all files
Apr 9, 2021	DEF 14A	Proxy statement	May 26, 2021	all files
Apr 17, 2020	DEFA14A	Extra proxy material		all files
Mar 27, 2020	DEFA14A	Extra proxy material		all files
Mar 27, 2020	DEF 14A	Proxy statement	May 21, 2020	all files
Mar 29, 2019	DEFA14A	Extra proxy material		all files
Mar 29, 2019	DEF 14A	Proxy statement	May 15, 2019	all files
Mar 14, 2019	PRE 14A		May 15, 2019	all files
Apr 2, 2018	DEFA14A	Extra proxy material		all files
Apr 2, 2018	DEF 14A	Proxy statement	May 16, 2018	all files
Mar 9, 2018	PRE 14A		Apr 19, 2018	all files
Mar 31, 2017	DEFA14A	Extra proxy material		all files
Mar 31, 2017	DEF 14A	Proxy statement	May 18, 2017	all files
Mar 10, 2017	PRE 14A		May 18, 2017	all files
Apr 1, 2016	DEFA14A	Extra proxy material		all files
Apr 1, 2016	DEF 14A	Proxy statement	May 19, 2016	all files
Apr 1, 2015	DEFA14A	Extra proxy material		all files
Apr 1, 2015	DEF 14A	Proxy statement	May 13, 2015	all files
Sep 23, 2014	DEFA14A	Extra proxy material		all files
Sep 23, 2014	DEF 14A	Proxy statement	Nov 5, 2014	all files
Sep 8, 2014	PRE 14A		Nov 5, 2014	all files
Apr 1, 2014	DEFA14A	Extra proxy material		all files
Apr 1, 2014	DEF 14A	Proxy statement	May 14, 2014	all files

Show the other 14 filings on this page

Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.

Next Earnings releases →